Research progression of raltitrexed in the treatment of gastric cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 535-537, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-494786
ABSTRACT
Raltitrexed is a specific inhibitor of thymidylate synthase,and has been confirmed that ralti-trexed has no cross tolerance with 5-fluorouracil.Studies have shown that raltitrexed-based combination chemo-therapy has a beneficial effect on the treatment of advanced gastric cancer,and well tolerance,which is worthy of clinical use.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS